Important Statistical Considerations For Developing Equations For Disease Simulators
Ishak, K.J, Kansal, A, Krotneva, M, Tarko, L, Tafazzoli, A
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article
Prognostic factors in crizotinib (CRZ)-resistant anaplastic lymphoma kinase (ALK+) non-small cell lung cancer (NSCLC) patients (Pts)
Reckamp, K.L., Lee, J., Huang, J., Proskorovsky, I., Reichmann, W., Krotneva, M., Kerstein, D., Huang, H.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
PSY55 - Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)
Pelligra, C, Guo, S, Parikh, K, Zhang, S, Krotneva, M, Onyekwere, U, Clancy, Z
Published in Value in health (01.05.2018)
Published in Value in health (01.05.2018)
Get full text
Journal Article
Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)
Pelligra, C, Guo, S, Parikh, K, Zhang, S, Krotneva, M, Onyekwere, U, Clancy, Z
Published in Value in health (01.05.2018)
Published in Value in health (01.05.2018)
Get full text
Journal Article
PRM143 - Important Statistical Considerations For Developing Equations For Disease Simulators
Ishak, K.J., Kansal, A., Krotneva, M., Tarko, L., Tafazzoli, A.
Published in Value in health (01.05.2015)
Published in Value in health (01.05.2015)
Get full text
Journal Article